← Back
$BBOT All transactions

BridgeBio Oncology Therapeutics, Inc.

M

$ Value

$0

Shares

30,000

Price

$0

Filed

Aug 11

Insider

Name

Holman Albert A III

Title

CIK

0002056154

Roles

Other

Transaction Details

Transaction Date

2025-08-11

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

In connection with and prior to the closing of the business combination between the Issuer (which was formerly known as Helix Acquisition Corp. II, "Helix") and TheRas, Inc., among other things, (i) each of Helix's Class B ordinary shares converted into one Helix Class A ordinary share, on a one-for-one basis, as described under the heading "Description of Securities" in Helix's Registration Statement on Form S-1 (File No. 333-276591), (ii) Helix migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication"), and (iii) as a result of the Domestication, each Class A ordinary share of Helix converted into one share of the Issuer's common stock, on a one-for-one basis. Prior to such conversion, the Helix Class B ordinary shares had no expiration date.

Filing Info

Accession No.

0001213900-25-074375

Form Type

4

Issuer CIK

0001869105

Holman Albert A III's History

Date Ticker Type Value
2025-08-11 BBOT M
2025-08-11 BBOT M $0

Other Insiders at BBOT (90d)

Insider Bought Sold Last
Lebowitz Peter F 2026-03-24